Afya Ltd
AFYA
9.53
-0.19
-1.95%
Afya Ltd
US · AFYA
#3110 by market cap
Listed 2019
9.53
-0.19
-1.95%
Periodic snapshot; not a real-time feed.
· 2026-11-20 16:10
Recent news
-
Rating change
BofA Securities Maintains Afya Ltd(AFYA.US) With Hold Rating, Maintains Target Price $17Market Newswire · 2026/4/22
-
Rating change
J.P. Morgan Downgrades Afya Ltd(AFYA.US) to Hold Rating, Cuts Target Price to $22Market Newswire · 2026/1/7
-
Company notice
Afya Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nicolau Carvalho Esteves(17.4%),Rosângela de Oliveira Tavares Esteves(17.4%), etc.SEC · 2024/11/15
-
Afya Backs 2026 Rev BRL3.95B-BRL4.1B AFYADow Jones · 2026/11/13
-
Company notice
Afya Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lílian Tavares Esteves de Carvalho(3.3%),LTE B Ventures Limited(3.3%), etc.SEC · 2024/11/15
-
Rating change
UBS Downgrades Afya Ltd(AFYA.US) to Hold Rating, Cuts Target Price to $16Market Newswire · 2026/1/16
-
Rating change
J.P. Morgan Maintains Afya Ltd(AFYA.US) With Hold Rating, Cuts Target Price to $21.5Market Newswire · 2026/4/30
-
Company notice
Afya Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Renato Tavares Esteves(3.3%),RTE B Ventures Limited(3.3%), etc.SEC · 2024/11/15
-
Rating change
J.P. Morgan Maintains Afya Ltd(AFYA.US) With Hold Rating, Cuts Target Price to $21Market Newswire · 2026/6/22
-
Rating change
UBS Maintains Afya Ltd(AFYA.US) With Buy Rating, Cuts Target Price to $18Market Newswire · 2026/1/8
-
Company notice
Afya Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Vanessa Tavares Esteves(3.1%),VTE B Ventures Limited(3.1%), etc.SEC · 2024/11/15
-
Company notice
Afya Ltd | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lílian Tavares Esteves de Carvalho(3.3%),LTE B Ventures Limited(3.3%), etc.SEC · 2024/11/15
-
BofA Securities Upgrades Afya Ltd(AFYA.US) to Buy Rating, Cuts Target Price to $16Market Newswire · 2026/10/29
-
Rating change
BTG Pactual Downgrades Afya Ltd(AFYA.US) to Hold Rating, Cuts Target Price to $17Market Newswire · 2026/1/21
-
Rating change
BofA Securities Downgrades Afya Ltd(AFYA.US) to Hold Rating, Cuts Target Price to $17Market Newswire · 2026/2/24
-
BofA Securities Maintains Afya Ltd(AFYA.US) With Buy RatingMarket Newswire · 2026/11/14
-
J.P. Morgan Upgrades Afya Ltd(AFYA.US) to Buy Rating, Cuts Target Price to $19Market Newswire · 2026/10/7
-
J.P. Morgan Maintains Afya Ltd(AFYA.US) With Buy Rating, Cuts Target Price to $17.5Market Newswire · 2026/11/3
-
Rating change
UBS Maintains Afya Ltd(AFYA.US) With Hold Rating, Maintains Target Price $16Market Newswire · 2026/1/16
-
Rating change
BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating, Announces Target Price $22Market Newswire · 2025/12/9
-
Press Release: Afya Limited and Yduqs Participações S.A. Enter Into Merger AgreementDow Jones · 2026/9/24
-
Rating change
BofA Securities Maintains Afya Ltd(AFYA.US) With Buy RatingMarket Newswire · 2025/11/13
-
Afya GAAP EPS of R$2.22 Beats by R$1.85, Revenue of R$972MSeeking Alpha · 2026/8/14
-
Rating change
Morgan Stanley Downgrades Afya Ltd(AFYA.US) to Hold Rating, Maintains Target Price $17.5Market Newswire · 2025/11/13
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 16:10:03 · For reference only, not investment advice and not tailored to your situation.
Afya Ltd discussion 0 comments